Philadelphia Area Resources for COVID-19

Opioid Epidemic Response Training

The Health Federation of Philadelphia believes that every person deserves health care whether or not they are in recovery and works in collaboration with the Philadelphia Department of Public Health to provide programs to train providers how to treat opioid use disorder and conditions related to substance use.

Our trainings emphasize harm reduction, the use of medications for opioid use disorder in primary care settings, trauma informed practice and treatment of comorbidities associated with substance use.

 If you’d like to join our mailing list to be notified of new programs, please contact Caroline Drob, Opioid Response Program Assistant at cdrob@healthfederation.org

*all didactic training will be online unless otherwise noted

 

We offer:

  • 8 Hour Waiver Training
  • Medications for Opioid Use Disorder (MOUD) Preceptor Program for PCPs
  • Monthly MOUD Provider Collaborative
  • 12-Month Series: Treating and Understanding Health Outcomes for People Who Use Drugs

8 Hour Live Waiver Training

Waiver trainings are offered quarterly to enable MD/DOs, Nurse Practitioners, and Physician Assistants in Pennsylvania to prescribe buprenorphine to patients for the treatment of opioid use disorder.  AAAP is the Data Sponsor for this waiver training. pcss@aaap.org in coordination with the Philadelphia Department of Public Health and the Health Federation of Philadelphia.

Upcoming waiver trainings are scheduled for:

      Tuesday, September 21, 2021

At the conclusion of this activity participants should be able to:

  • Screen and identify patients with OUD and define evidence-based treatments.
  • Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
  • Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
  • Explain the process of buprenorphine induction as well as stabilization and maintenance.
  • Discuss all FDA approved antagonist and agonist medications to treat OUD.
  • Discuss basic office protocols including medical record documentation and confidentiality.
  • Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
  • Recognize the importance of obtaining a waiver to begin treating patients with OUD.

“Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.”

 

Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the American Academy of Addiction Psychiatry , Philadelphia Department of Public Health, and Health Federation of Philadelphia. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Designation Statement: American Academy of Addiction Psychiatry designates this live course for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Designation Statement:  American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider # 4008192.  This program is approved for up to 8 Nursing Contact Hours.

 

PA Designation Statement:

American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits.  PAs should only claim credit commensurate with the extent of their participation. 

 

MOUD Preceptor Training is designed to address the practical day-to-day questions that arise when treating patients for OUD in primary care settings.  These small group CME accredited trainings offer a full day of didactic training online followed by an individual or small group clinical experience with experienced faculty either online or on-site.  On-site sessions are limited and must be scheduled individually upon receipt of CV, proof of waiver, and medical license.

See below for dates and registration links.

For more information and to register, click on the training date you’d like to attend (online):

         Part A: Monday, October 18, 2021 from 8:30 am - 4:30 pm

Part B Sessions are offered throughout the year and participants may choose between an on-site observation or an online clinical experience with experienced faculty preceptors.  Online sessions may include an encounter with a Standardized Patient.  

MOUD Provider Collaborative is offered to waivered Primary Care Providers who want to learn from and network with their peers.  Most sessions offer a brief presentation on timely issues led by local practitioners followed by open discussion.  These are currently scheduled online for the 4th Thursday of the month from 8:00 am to 9:00 am.  

If you are interested in attending these sessions, please contact Caroline Drob, Opioid Response Program Assistant at cdrob@healthfederation.org

12-Month Series: Treating and Understanding Health Outcomes for People Who Use Drugs

These programs will address factors influencing health outcomes associated with substance use, including infectious diseases and support health providers in Philadelphia to screen for and treat comorbidities.  Monthly case review sessions will describe concurrent treatment of OUD and comorbidities such as STIs, soft tissue infections, HCV, HIV, and others, while special programs will present timely topics related to substance use and infectious disease treatment outcomes.  These programs are accredited for CME and are open to all.  Registration is required.  

Special Topics

2nd Monday Case Review Series features patient cases that demonstrate concurrent treatment of opioid use disorder (OUD) and comorbidities associated with substance use.  These sessions are CME accredited and are open to all disciplines.  Registration is required.

September 9, 2021 from 10:00 am - 11:00 am,  Provider Update: Clinical Implications from National and Local Drug User Health Surveys

October 4, 2021 from 12:15 - 1:15 pm. Second Monday Case Review: STIs Screenings and OUD Care. Featuring Gina Simoncini, MD MPH FACP AAHIVS

Save the date: November 8, 2021 from 12:15 pm - 1:15 pm. Second Monday Case Review: Perinatal HIV and OUD. Featuring Shelia Henry, CRNP AAHIVS.

Coming Soon:

Save the date: 3-part virtual series on developing safety in SUD settings:

November 16, 2021 from 10:00 am - 11:30 am. Taking a Trauma-Informed Sexual History. Featuring Laura Hinds, MSW, LCSW

December 14, 2021 from 1:00 pm - 3:00 pm. Safety in the Patient-Provider Relationship. Featuring Rebecca Bryan,  DNP, AGPCNP, APN

January 11, 2022 from 1:00 pm - 3:00 pm. Taking a Trauma-Informed Substance Use History. Featuring Silvana Mazzella, BSW, MA

 

         If you’d like to join our mailing list to be notified of new programs, please contact Caroline Drob, Opioid Response Program Assistant at cdrob@healthfederation.org